With this type of mild cognitive impairment, a person experiences cognitive decline in places aside from memory. It'd be problem with reasoning, judgment, language or interaction.The extension analyze also evaluated CLARITY AD individuals who experienced a delayed start off (people who switched from placebo to lecanemab once the core trial) and fou